Hims & Hers Health Inc (HIMS) Stock Price & News

Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia

About Hims & Hers Health Inc

CEO-

Employees2,44 миң

Foundedноя. 2017

HeadquartersСан Франциско, Калифорния, Америка Кошмо Штаттары

SectorHealth care provider

Websitehims.com

Analyst	Recommendation	Action	Price target	Projected	Date
Allen Lutz Bank of America Securities	Hold	Reiterated	32,00 USD	+8,6%	09/25/2026
Jailendra Singh Truist Financial	Hold	Reiterated	32,00 USD	+8,6%	09/11/2026
Bryan Smilek J.P. Morgan	Hold	Initiated	32,00 USD	+8,6%	09/11/2026
Brian Tanquilut Jefferies	Hold	Maintained	31,00 USD	+5,2%	09/03/2026
Justin Patterson KeyBanc	Hold	Maintained	-	-	09/02/2026
Glen Santangelo Barclays	Buy	Reiterated	35,00 USD	+18,8%	08/20/2026
George Hill Deutsche Bank	Hold	Reiterated	26,00 USD	-11,8%	08/11/2026
Jonna Kim TD Cowen	Hold	Reiterated	30,00 USD	+1,8%	08/11/2026
Craig Hettenbach Morgan Stanley	Hold	Reiterated	28,00 USD	-5%	08/11/2026
Maria Ripps Canaccord Genuity	Buy	Reiterated	40,00 USD	+35,7%	08/11/2026
Ryan MacDonald Needham	Buy	Reiterated	42,00 USD	+42,5%	08/11/2026
David Larsen BTIG	Hold	Reiterated	-	-	08/11/2026
Daniel Grosslight Citi	Hold	Maintained	33,00 USD	+12%	08/12/2026
Mark Mahaney Evercore ISI	Hold	Maintained	-	-	08/11/2026
Oliver Chen TD Cowen	Hold	Reiterated	25,00 USD	-15,2%	05/12/2026
Cory Carpenter J.P. Morgan	Buy	Maintained	33,00 USD	+12%	05/12/2026
Michael Cherny Leerink Partners	Hold	Maintained	-	-	04/16/2026
Unknown Analyst Nephron	Buy	Upgraded	35,00 USD	+18,8%	03/09/2026

All values in USD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	598,98 млн	617,82 млн	608,10 млн	753,21 млн
Cost of goods sold	156,92 млн	173,38 млн	182,82 млн	272,41 млн
Cost of revenue	156,92 млн	173,38 млн	182,82 млн	272,41 млн
Research and development expenses	40,58 млн	40,96 млн	46,94 млн	54,90 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	389,67 млн	386,64 млн	426,37 млн	521,95 млн
Operating expense	430,25 млн	427,60 млн	473,31 млн	576,85 млн
Total operating expenses	587,17 млн	600,99 млн	656,13 млн	849,26 млн
Operating income	11,81 млн	16,83 млн	-48,02 млн	-96,04 млн
Other non operating income	-5,99 млн	-575,00 миң	-18,58 млн	-2,43 млн
EBT including unusual items	12,22 млн	18,35 млн	-101,55 млн	-92,63 млн
EBT excluding unusual items	12,22 млн	21,56 млн	-61,57 млн	-96,22 млн
Income tax expense	-3,55 млн	-2,25 млн	-9,44 млн	-6,34 млн
Effective tax rate	-29,05%	-12,25%	9,29%	6,85%
Other operating expenses	-	-	-	-
Net income	15,77 млн	20,60 млн	-92,12 млн	-86,29 млн
Net profit margin	2,63%	3,33%	-15,15%	-11,46%
Earnings per share	0,28	0,22	-0,19	-0,09
Interest and investment income	8,01 млн	6,80 млн	7,90 млн	6,00 млн
Interest expense	-1,60 млн	-1,50 млн	-2,87 млн	-3,75 млн
Net interest expenses	6,41 млн	5,30 млн	5,03 млн	2,25 млн
Depreciation and amortization charges	-	-	-	-
EBITDA	29,48 млн	34,92 млн	-26,07 млн	-66,57 млн
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything